These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 36000917)

  • 1. Urine N-terminal pro-B-type natriuretic peptide and plasma proenkephalin are promising biomarkers for early diagnosis of cardiorenal syndrome type 1 in acute decompensated heart failure: a prospective, double-center, observational study in real-world.
    Zhao HL; Hu HJ; Zhao XJ; Chi WW; Liu DM; Wang Q; Cui W
    Ren Fail; 2022 Dec; 44(1):1486-1497. PubMed ID: 36000917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Verdiani V; Tijssen JG; Pinto YM
    JACC Heart Fail; 2015 Oct; 3(10):751-61. PubMed ID: 26449995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial fibrosis combined with NT-proBNP improves the accuracy of survival prediction in ADHF patients.
    Yao Y; Feng L; Sun Y; Wang S; Sun J; Hu B
    BMC Cardiovasc Disord; 2021 May; 21(1):264. PubMed ID: 34049488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in the NT-proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome.
    Takahama H; Nishikimi T; Takashio S; Hayashi T; Nagai-Okatani C; Asada T; Fujiwara A; Nakagawa Y; Amano M; Hamatani Y; Okada A; Amaki M; Hasegawa T; Kanzaki H; Nishimura K; Yasuda S; Kangawa K; Anzai T; Minamino N; Izumi C
    J Am Heart Assoc; 2019 Sep; 8(17):e011468. PubMed ID: 31441355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.
    Flores-Blanco PJ; Manzano-Fernández S; Pérez-Calvo JI; Pastor-Pérez FJ; Ruiz-Ruiz FJ; Carrasco-Sánchez FJ; Morales-Rull JL; Pascual-Figal D; Galisteo-Almeda L; Januzzi JL
    Clin Cardiol; 2015 Feb; 38(2):106-13. PubMed ID: 25663560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative prognostic value of plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute destabilized heart failure].
    Manzano-Fernández S; Januzzi JL; Boronat García M; Bonaque-González JC; Muñoz-Esparza C; Albaladejo-Otón MD; Pastor-Pérez FJ; Pastor P; Valdés M; Pascual-Figal DA
    Rev Esp Cardiol; 2011 May; 64(5):365-72. PubMed ID: 21397374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure.
    Kim SE; Cho DH; Son JW; Kim JY; Kang SM; Cho MC; Lee HY; Choi DJ; Jeon ES; Yoo BS
    Int J Cardiol; 2022 Sep; 363():163-170. PubMed ID: 35753618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of plasma biomarkers in discharged heart failure patients: role of plasma NT-proBNP.
    Leto L; Testa M; Feola M
    Minerva Cardioangiol; 2016 Apr; 64(2):157-64. PubMed ID: 26373781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
    Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
    Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Measurements Until a 30% Reduction Is Attained During Acute Decompensated Heart Failure Admissions and Comparison With Discharge NT-proBNP Levels: Implications for In-Hospital Guidance of Treatment.
    Stienen S; Salah K; Dickhoff C; Carubelli V; Metra M; Magrini L; Di Somma S; Tijssen JP; Pinto YM; Kok WE
    J Card Fail; 2015 Nov; 21(11):930-4. PubMed ID: 26216495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Functions and Prognosis Stratification in Chronic Heart Failure Patients and the Importance of Neutrophil Gelatinase-Associated Lipocalin.
    Lábr K; Špinar J; Pařenica J; Špinarová L; Málek F; Špinarová M; Ludka O; Jarkovský J; Benešová K; Goldbergová-Pávková M; Lábrová R
    Kidney Blood Press Res; 2018; 43(6):1865-1877. PubMed ID: 30537724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine N-terminal pro b-type natriuretic peptide is predictive of heart failure-related emergency department visits.
    Chen JY; Lee SY; Tsai WC; Lin CY; Shieh MD; Ciou DS
    ESC Heart Fail; 2020 Oct; 7(5):2672-2678. PubMed ID: 32613707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea.
    Shah RV; Truong QA; Gaggin HK; Pfannkuche J; Hartmann O; Januzzi JL
    Eur Heart J; 2012 Sep; 33(17):2197-205. PubMed ID: 22645194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of Kidney Function Decline and NT-proBNP With Risk of Mortality and Readmission in Acute Decompensated Heart Failure.
    McCallum W; Tighiouart H; Kiernan MS; Huggins GS; Sarnak MJ
    Am J Med; 2020 Jan; 133(1):115-122.e2. PubMed ID: 31247182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary C-type natriuretic peptide: a new heart failure biomarker.
    Zakeri R; Sangaralingham SJ; Sandberg SM; Heublein DM; Scott CG; Burnett JC
    JACC Heart Fail; 2013 Apr; 1(2):170-7. PubMed ID: 24244916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Pedretti RF; Lagioia R; Frigerio M; Catanzaro R; Oliva F
    Int J Cardiol; 2013 Oct; 168(3):2120-6. PubMed ID: 23395457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality.
    deFilippi CR; Seliger SL; Maynard S; Christenson RH
    Clin Chem; 2007 Aug; 53(8):1511-9. PubMed ID: 17586595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: A novel compensatory mechanism for acute heart failure.
    Takahama H; Takashio S; Nishikimi T; Hayashi T; Nagai-Okatani C; Nakagawa Y; Amaki M; Ohara T; Hasegawa T; Sugano Y; Kanzaki H; Yasuda S; Kangawa K; Minamino N; Anzai T
    Int J Cardiol; 2018 May; 258():165-171. PubMed ID: 29544926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.